Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients-Reference-Cited by-同舟云学术

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

Published:2019-08 Issue: Volume:117 Page:107-115
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Yao Zong-Han,Liao Wei-Yu^ORCID,Ho Chao-Chi,Chen Kuan-Yu,Shih Jin-Yuan,Chen Jin-Shing,Lin Zhong-Zhe,Lin Chia-Chi,Yang James Chih-Hsin,Yu Chong-Jen

Funder

AstraZeneca

Roche

Boehringer Ingelheim

Lilly

Pfizer

MSD

Novartis

Bristol-Myers Squibb

Genentech

Chugai

BMS

Merck Sharp and Dohme

Chugai Pharmaceutical

Merck Sharp & Dohme

AbbVie

Ono Pharmaceutical

Bayer

Astellas

Merck

Celgene

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet (London, England),2015

2. Perspectives and control of hepatitis B virus infection in Taiwan;Lin;Journal of the Formosan Medical Association = Taiwan yi zhi.,2015

3. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study;Hsu;Hepatology (Baltimore, Md),2014

4. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors;Yeo;J Med Virol,2000

5. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study;Seto;J Clin Oncol Off J Am Soc Clin Oncol,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis;Seminars in Oncology;2024-08

2. Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors;World Journal of Gastroenterology;2024-06-28

3. Hepatitis B Virus Reactivation After Pralsetinib-Targeted Therapy in a Patient With Non–Small Cell Lung Cancer;American Journal of Therapeutics;2024-02-28

4. A Review of Hepatitis B Reactivation Risk on Immunosuppressants with a Focus on Newer Immunomodulators;Current Hepatology Reports;2024-02-28

5. Post-transplant HBV reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-center retrospective cohort study in China;International Journal of Surgery;2024-02-09